Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Snhg14 Lncrna As a Prognostic Biomarker in Adult Non-M3 Aml Patients Publisher Pubmed



Seifpour S1 ; Zomorrod MS1 ; Atashi A2 ; Khaseb S1 ; Tavangar F3 ; Vajari MK4 ; Ahmadvand M5
Authors

Source: Hematology/oncology and stem cell therapy Published:2025


Abstract

BACKGROUND AND OBJECTIVES: Acute myeloid leukemia (AML) is one of the most common blood malignancies in adults, characterized by the involvement of hematopoietic myeloid progenitors. Numerous studies have demonstrated the involvement of long noncoding RNAs (lncRNAs) in AML pathogenesis. This study aimed to investigate the expression profile of lncRNA small nuclear RNA host gene 14 (SNHG14) and its role in the pathogenesis, clinical features, and prognosis of adult non-M3 AML. MATERIALS AND METHODS: The expression level of SNHG14 was evaluated in bone marrow (BM) samples obtained from 50 adult non-M3 AML patients and 49 healthy controls using Quantitative Reverse Transcription-Polymerase Chain Reaction. We also investigated the correlation between clinicopathological characteristics and SNHG14 expression levels in AML patients. RESULTS: The expression level of SNHG14 was significantly decreased in the BM tissues of adult non-M3 AML patients compared to healthy controls. Patients with low SNHG14 expression were associated with poor overall survival, while no correlation was found between low SNHG14 expression and relapse-free survival. CONCLUSION: Our findings suggest that SNHG14 expression could serve as a potential biomarker for prognosing adult non-M3 AML patients. Furthermore, SNHG14 may offer insights into novel therapeutic targets for this subset of AML patients. Copyright © 2025 Hematology/Oncology and Stem Cell Therapy.
Related Docs
View other Related Docs
1. Expression Analysis of Pvt1, Ccdc26, and Ccat1 Long Noncoding Rnas in Acute Myeloid Leukemia Patients, Genetic Testing and Molecular Biomarkers (2018)
2. Low Expression of Long Noncoding Rna Irain Is Associated With Poor Prognosis in Non-M3 Acute Myeloid Leukemia Patients, Genetic Testing and Molecular Biomarkers (2018)
3. Identification of Lncrnas Associated With the Progression of Acute Lymphoblastic Leukemia Using a Competing Endogenous Rnas Network, Oncology Research (2022)
Experts (# of related papers)
View all Related Experts
Mohammad Ahmadvand (4)
Marjan Yaghmaie (4)
Other Related Docs
4. Expression Pattern of Key Micrornas in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase, International Journal of Laboratory Hematology (2015)
5. Long Non-Coding Rnas (Lncrnas) As Prognostic and Diagnostic Biomarkers in Multiple Myeloma: A Systematic Review and Meta-Analysis, Pathology Research and Practice (2022)
6. Parp-1 Overexpression As an Independent Prognostic Factor in Adult Non-M3 Acute Myeloid Leukemia, Genetic Testing and Molecular Biomarkers (2018)
7. Circulating Mirnas Can Serve As Potential Diagnostic Biomarkers in Chronic Myelogenous Leukemia Patients, Leukemia Research Reports (2021)
8. Deregulation of Mir-1, Mir486, and Let-7A in Cytogenetically Normal Acute Myeloid Leukemia: Association With Npm1 and Flt3 Mutation and Clinical Characteristics, Tumor Biology (2016)
9. Investigation Methylation Status of Tumor Suppressor Gene Nr4a1 and Nr4a3 and Frequency of Rs1569686 Polymorphism of Dnmt3b Gene in Patients With Acute Myeloid Leukemia, Molecular Biology Research Communications (2025)
10. Fas-Antisense Long Noncoding Rna and Acute Myeloid Leukemia: Is There Any Relation?, Asian Pacific Journal of Cancer Prevention (2018)
11. The Role of Micrornas in Myeloproliferative Neoplasia, International Journal of Hematology-Oncology and Stem Cell Research (2016)
12. Upregulation of Lnc-Foxd2-As1, Cdc45, and Cdk1 in Patients With Primary Non-M3 Aml Is Associated With a Worse Prognosis, Blood Research (2024)
13. Long Non-Coding Rna Signatures in Lymphopoiesis and Lymphoid Malignancies, Non-coding RNA (2023)
14. Expression Analysis of Becn1 in Acute Myeloid Leukemia: Association With Distinct Cytogenetic and Molecular Abnormalities, International Journal of Laboratory Hematology (2016)
15. Hotair Long Noncoding Rna Is Not a Biomarker for Acute Myeloid Leukemia (Aml) in Iranian Patients, Asian Pacific Journal of Cancer Prevention (2017)
16. High Expression of Long Noncoding Rna Norad Is Associated With Poor Clinical Outcomes in Non-M3 Acute Myeloid Leukemia Patients, Hematology/ Oncology and Stem Cell Therapy (2023)
17. Indirect Tumor Inhibitory Effects of Microrna-124 Through Targeting Ezh2 in the Multiple Myeloma Cell Line, Cell Journal (2020)
18. Expression Analysis of Circulating Plasma Long Noncoding Rnas in Colorectal Cancer: The Relevance of Lncrnas Atb and Ccat1 As Potential Clinical Hallmarks, Journal of Cellular Physiology (2019)
19. Expression of Tnf-And Hnrnpl-Related Immunoregulatory Long Non-Coding Rna (Thril) in Acute Myeloid Leukemia: Is There Any Correlation?, Iranian Journal of Allergy# Asthma and Immunology (2018)
20. Upregulation of the Long Noncoding Rna Gja9-Mycbp and Pvt1 Is a Potential Diagnostic Biomarker for Acute Lymphoblastic Leukemia, Cancer Reports (2024)